Zobrazeno 1 - 10 of 10 pro vyhledávání: '"Joseph R. Hartmann"'
1
Recanalization of chronically occluded aortocoronary saphenous vein bypass grafts with long-term, low dose direct infusion of urokinase (ROBUST): A serial trial
Autor: Andrew J. Doorey, Christopher J. White, Louis S. McKeever, Patrick L. Whitlow, William W. O'Neill, Elaine L. Enger, Joseph P. Galichia, Joseph R. Hartmann, Paul Gilmore
Publikováno v: Journal of the American College of Cardiology. 27:60-66
Objectives. This multicenter study sought to evaluate the shortterm efficacy and safety of prolonged, low dose, direct urokinase infusion in recanalization of chronically occluded saphenous vein bypass grafts in a large sample of patients, as well as
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6f5e14c5a977edb24f10bff86db1b44
https://doi.org/10.1016/0735-1097(95)00448-3
Zobrazit plný text záznamu
2
Clinical Studies with the New Glycosylated Recombinant Prourokinase
Autor: Walter M. Barker, Arthur A. Sasahara, Jeffrey L. Anderson, Joseph R. Hartmann, Esther M. Villiard, W. Douglas Weaver, P.Sudhakar Reddy
Publikováno v: Journal of Vascular and Interventional Radiology. 6:84S-93S
Recombinant prourokinase (r-ProUK) is a single-chain urokinase-type plasminogen activator that is produced from a mammalian cell line. It is administered as a zymogen and remains inactive until converted to the active two-chain form on the surface of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77342afe6919a44f0fac02ffb3026794
https://doi.org/10.1016/s1051-0443(95)71255-6
Zobrazit plný text záznamu
3
New recombinant glycosylated prourokinase for treatment of patients with acute myocardial infarction
Autor: Joseph R. Hartmann, Jeffrey L. Anderson, P.Sudhakar Reddy, Arthur A. Sasahara, John C. Sobolski, W. Douglas Weaver
Publikováno v: Journal of the American College of Cardiology. 24:1242-1248
Objectives. Three dosage regimens of a new recombinant glycosylated prourokinase (A-74187) were evaluated by measuring coronary artery patency at 90 min in patients with acute myocardial infarction. Background. Prourokinase is a thrombolytic drug wit
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9c5219ebb3c843bc26b7e84fe790b93
https://doi.org/10.1016/0735-1097(94)90105-8
Zobrazit plný text záznamu
4
The effect of predilatation on coronary angioplasty-induced vessel wall injury
Autor: Alan S. Brown, Nicholas J. Stamato, John M. Cahill, Elaine L. Enger, Louis S. McKeever, Joseph C. Marek, Michael J. O'Donnell, Joseph R. Hartmann
Publikováno v: American Heart Journal. 122:1515-1518
Fifty-four patients presenting with stenotic lesions in a major coronary artery visually estimated by diagnostic angiography to be greater than 90% but less than 100% were randomized to one of two angioplasty regimens, predilatation (group 1) or no p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa5828a44f5518af9c2f29bfa529af97
https://doi.org/10.1016/0002-8703(91)90265-j
Zobrazit plný text záznamu
5
Recanalization of chronically occluded aortocoronary saphenous vein bypass grafts by extended infusion of urokinase: Initial results and short-term clinical follow-up
Autor: Joseph C. Marek, Louis S. McKeever, Joseph R. Hartmann, John M. Cahill, Nicholas J. Stamato, Vincent J. Bufalino, Alan S. Brown, Mark J. Goodwin, Elaine L. Enger
Publikováno v: Journal of the American College of Cardiology. 18:1517-1523
Chronic occlusion of saphenous vein aortocoronary bypass grafts is a common problem. Although percutaneous transluminal angioplasty of a saphenous vein with a stenotic lesion is feasible, angioplasty alone of a totally occluded vein graft yields unif
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93f36efa293f75c712df9e7f7dc26fa6
https://doi.org/10.1016/0735-1097(91)90684-2
Zobrazit plný text záznamu
6
Antiplatelet therapy in the prevention of ischemic vascular events: literature review and evidence-based guidelines for drug selection
Autor: James H. Chesebro, Randall M. Zusman, Eric Raps, Anthony Comerota, Philip A. Wolf, Edward K. Massin, Joseph R. Hartmann
Publikováno v: Clinical cardiology. 22(9)
Background: New antiplatelet drugs are being developed and many clinical trials evaluating the benefits of antiplatelet drugs for the secondary prevention of ischemic events in patients with atherosclerotic vascular disease have been performed. Hypot
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58f2ca6cf6f2359cd429c745d30919cc
https://pubmed.ncbi.nlm.nih.gov/10486695
Zobrazit plný text záznamu
7
738–6 Recanalization of Chronically Occluded Bypass Grafts: The Effect of Angioplasty Site Following Extended Urokinase Infusion on 6 Month Patency
Autor: Joseph R. Hartmann, Louis S. McKeever, Christopher J. White, Patrick J. Whitlow, Elaine L. Enger, William W. O'Neill
Publikováno v: Journal of the American College of Cardiology. 25:149A-150A
One hundred seven patients with chronically occluded aortocoronary bypass grafts were enrolled in the ROBUST trial to determine the safety and efficacy of low dose, long-term urokinase intracoronary infusions in recanalizing these vessels. Initial pa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fec3c2323bf6ed501c087432c048c77
https://doi.org/10.1016/0735-1097(95)92075-g
Zobrazit plný text záznamu
8
715-3 Cost Implications of Aortic Counterpulsation in Acute Myocardial Infarction: Results from a Randomized Clinical Trial
Autor: Joseph R. Hartmann, Harry R. Phillips, J. David Talley, Lisa G. Berdan, Robert M. Califf, Daniel B. Mark, Christopher J. White, Morton J. Kern, Conor Lundergan, Paul A. Gurbel, E. Magnus Ohman, Lai Choi Lam, Barry S. George
Publikováno v: Journal of the American College of Cardiology. 25:87A
To evaluate the cost implications of prophylactic aortic counterpulsation (IASP) to sustain coronary artery patency during acute myocardial infarction. we evaluated 102 (55%) from the 182 patients enrolled in the randomized IABP study. After coronary
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4b5b1a209c3782733d81e27a681c347
https://doi.org/10.1016/0735-1097(95)91812-c
Zobrazit plný text záznamu
9
Chemotactic activity in the coronary sinus after experimental myocardial infarction: Effects of pharmacologic interventions on ischemic injury
Autor: John A. Robinson, Joseph R. Hartmann, Rolf M. Gunnar
Publikováno v: The American Journal of Cardiology. 40:550-555
Various pharmacologic interventions that suppressed chemotactic factor activity in the coronary sinus after acute ischemia were analyzed for protective effects on myocardium. Ischemic injury was determined by comparing the slopes of the regression li
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9191f3118ca77b075ef69979c238db6c
https://doi.org/10.1016/0002-9149(77)90070-4
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje